Brief: Investment Manager RA Capital Reports 9.99% Stake In Cidara Therapeutics
25/07/2024 23:07
July 25 (Reuters) -
RA Capital Management:
* RA CAPITAL MANAGEMENT, L.P. REPORTS 9.99% STAKE IN CIDARA
THERAPEUTICS AS OF JULY 18 - SEC FILING
Source text for Eikon: ID:n0001104659-24-082640
Further company coverage: CDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cidara Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merck Seeks Up To $8 Billion In Us Bond Sale Tied To Cidara Deal - Bloomberg News
Merck rises after Wells Fargo upgrades stock to 'overweight'
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade